These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. µ- and κ-Opioid receptor activation in the dorsal periaqueductal grey matter differentially modulates panic-like behaviours induced by electrical and chemical stimulation of the inferior colliculus. Twardowschy A; Coimbra NC Brain Res; 2015 Feb; 1597():168-79. PubMed ID: 25485771 [TBL] [Abstract][Full Text] [Related]
8. Recent Progress in Opioid Research from an Electrophysiological Perspective. Birdsong WT; Williams JT Mol Pharmacol; 2020 Oct; 98(4):401-409. PubMed ID: 32198208 [TBL] [Abstract][Full Text] [Related]
9. Mu opioid receptor activation enhances regulator of G protein signaling 4 association with the mu opioid receptor/G protein complex in a GTP-dependent manner. Santhappan R; Crowder AT; Gouty S; Cox BM; Côté TE J Neurochem; 2015 Oct; 135(1):76-87. PubMed ID: 26119705 [TBL] [Abstract][Full Text] [Related]
10. Involvement of µ-opioid Receptors and κ-opioid Receptors in Itch-related Scratching Behaviour of Imiquimod-induced Psoriasis-like Dermatitis in Mice. Takahashi N; Tominaga M; Kosaka R; Kamata Y; Umehara Y; Matsuda H; Sakaguchi A; Ogawa H; Takamori K Acta Derm Venereol; 2017 Aug; 97(8):928-933. PubMed ID: 28512665 [TBL] [Abstract][Full Text] [Related]
11. Differential Regulation of 6- and 7-Transmembrane Helix Variants of μ-Opioid Receptor in Response to Morphine Stimulation. Convertino M; Samoshkin A; Viet CT; Gauthier J; Li Fraine SP; Sharif-Naeini R; Schmidt BL; Maixner W; Diatchenko L; Dokholyan NV PLoS One; 2015; 10(11):e0142826. PubMed ID: 26554831 [TBL] [Abstract][Full Text] [Related]
12. The Quest for More Effective Analgesics with Reduced Abuse Liability and Fewer Adverse Effects: Promises, Pitfalls, and Future Perspectives of Biased Agonists at Opioid Receptors. Bedini A Methods Mol Biol; 2021; 2201():181-192. PubMed ID: 32975799 [TBL] [Abstract][Full Text] [Related]
13. Regional differences in mu and kappa opioid receptor G-protein activation in brain in male and female prairie voles. Martin TJ; Sexton T; Kim SA; Severino AL; Peters CM; Young LJ; Childers SR Neuroscience; 2015 Dec; 311():422-9. PubMed ID: 26523979 [TBL] [Abstract][Full Text] [Related]
14. HS-599: a novel long acting opioid analgesic does not induce place-preference in rats. Lattanzi R; Negri L; Giannini E; Schmidhammer H; Schutz J; Improta G Br J Pharmacol; 2001 Sep; 134(2):441-7. PubMed ID: 11564664 [TBL] [Abstract][Full Text] [Related]
15. Loss of TRPV1-expressing sensory neurons reduces spinal mu opioid receptors but paradoxically potentiates opioid analgesia. Chen SR; Pan HL J Neurophysiol; 2006 May; 95(5):3086-96. PubMed ID: 16467418 [TBL] [Abstract][Full Text] [Related]
16. Modulation of anxiety-related behaviors by mu- and kappa-opioid receptor agonists depends on the social status of mice. Kudryavtseva NN; Gerrits MA; Avgustinovich DF; Tenditnik MV; Van Ree JM Peptides; 2004 Aug; 25(8):1355-63. PubMed ID: 15350704 [TBL] [Abstract][Full Text] [Related]
17. YFa, a chimeric opioid peptide, induces kappa-specific antinociception with no tolerance development during 6 days of chronic treatment. Vats ID; Dolt KS; Kumar K; Karar J; Nath M; Mohan A; Pasha MA; Pasha S J Neurosci Res; 2008 May; 86(7):1599-607. PubMed ID: 18183621 [TBL] [Abstract][Full Text] [Related]
18. μ-Opioid receptor 6-transmembrane isoform: A potential therapeutic target for new effective opioids. Convertino M; Samoshkin A; Gauthier J; Gold MS; Maixner W; Dokholyan NV; Diatchenko L Prog Neuropsychopharmacol Biol Psychiatry; 2015 Oct; 62():61-7. PubMed ID: 25485963 [TBL] [Abstract][Full Text] [Related]
19. Mu and delta opioid receptor immunoreactivity and mu receptor regulation in brainstem cells cultured from late fetal and early postnatal rats. Kivell BM; Day DJ; McDonald FJ; Miller JH Brain Res Dev Brain Res; 2004 Mar; 149(1):9-19. PubMed ID: 15013624 [TBL] [Abstract][Full Text] [Related]
20. Synthetic Studies of Neoclerodane Diterpenes from Salvia divinorum: Identification of a Potent and Centrally Acting μ Opioid Analgesic with Reduced Abuse Liability. Crowley RS; Riley AP; Sherwood AM; Groer CE; Shivaperumal N; Biscaia M; Paton K; Schneider S; Provasi D; Kivell BM; Filizola M; Prisinzano TE J Med Chem; 2016 Dec; 59(24):11027-11038. PubMed ID: 27958743 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]